Classroom-Level Intervention to Promote Peers' Acceptance of Children With Attention Deficit Hyperactivity Disorder (ADHD)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01133028 |
Recruitment Status : Unknown
Verified May 2010 by University of Virginia.
Recruitment status was: Not yet recruiting
First Posted : May 28, 2010
Last Update Posted : May 28, 2010
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Attention Deficit Hyperactivity Disorder | Behavioral: Behavioral contingency management Behavioral: Tolerance training | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Estimated Enrollment : | 102 participants |
Allocation: | Randomized |
Intervention Model: | Crossover Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Treatment |
Official Title: | Classroom-Level Intervention to Promote Peers' Acceptance of Children With Attention-Deficit/Hyperactivity Disorder (ADHD) |
Study Start Date : | January 2011 |
Estimated Primary Completion Date : | September 2011 |
Estimated Study Completion Date : | June 2012 |

Arm | Intervention/treatment |
---|---|
Experimental: Combined
This represents a combination of the tolerance training and behavioral management interventions together.
|
Behavioral: Behavioral contingency management
Teachers will learn to use reinforcements and response cost procedures to encourage children's display of prosocial behaviors. Behavioral: Tolerance training Teachers will be instructed in procedures to encourage the peer group to be accepting of children with ADHD. |
Active Comparator: Behavioral management
This represents the behavioral contingency management intervention only.
|
Behavioral: Behavioral contingency management
Teachers will learn to use reinforcements and response cost procedures to encourage children's display of prosocial behaviors. |
- Child Peer Relationships [ Time Frame: The first day of the treatment and the last day of the treatment (two weeks later) ]This is collected in the summer program in which the intervention will be adminstered. On the first day of the program (before treatment begins), pre-test measures will be taken. They will be re-taken on the last day of the program two weeks later (on the last day of treatment). Peer relationships will be assessed by peer sociometric interviews. Proportion scores of peer acceptance, reciprocated friendship, and inclusion in social networks will be calculated, and changes in these outcomes over the summer prorgam will be considered as evidence to evaluate the treatment.
- Child Behavior Problems [ Time Frame: The first day of the treatment and the last day of the treatment (two weeks later) ]This measure will be collected on the same time frame as is the primary outcome measure. Children's behavior problems (aggression, inattention, hyperactivity/impulsivity, social withdrawal) will be assessed by teacher report and by observation. Changes in behavior problems during this period will be considered as evidence for the efficacy of the treatment.

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 6 Years to 8 Years (Child) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- Children ages 6-8
- Primary diagnosis of ADHD
Exclusion Criteria:
- Pervasive Developmental Disorder
- Verbal IQ below 75

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01133028
Contact: Amori Y Mikami, PhD | 4342432327 | mikami@virginia.edu |
United States, Virginia | |
University of Virginia | |
Charlottesville, Virginia, United States, 22904 | |
Contact: Amori Y Mikami, PhD 434-243-2327 mikami@virginia.edu | |
Principal Investigator: Amori Y Mikami, PhD |
Principal Investigator: | Amori Y Mikami, PhD | University of Virginia |
Responsible Party: | Amori Y Mikami, Assistant Professor, University of Virginia |
ClinicalTrials.gov Identifier: | NCT01133028 |
Other Study ID Numbers: |
2010-0066-00 |
First Posted: | May 28, 2010 Key Record Dates |
Last Update Posted: | May 28, 2010 |
Last Verified: | May 2010 |
Attention Deficit Hyperactivity Disorder (ADHD) |
Hyperkinesis Disease Attention Deficit Disorder with Hyperactivity Pathologic Processes Attention Deficit and Disruptive Behavior Disorders |
Neurodevelopmental Disorders Mental Disorders Dyskinesias Neurologic Manifestations Nervous System Diseases |